Axa Health has introduced a neurodiversity assessment and support service as part of its UK corporate private healthcare schemes.
The service will provide members with prompt assessments, diagnosis and onward assistance to empower and support them, while addressing the challenges of long wait times and access to expert practitioners, the insurer said.
It is supported by ProblemShared and will offer an initial needs assessment and where appropriate, diagnosis and a package of post-assessment support for autism, attention deficit hyperactivity disorder (ADHD), dyslexia, dysgraphia and dyscalculia.
The benefit will be available to add to corporate schemes at renewal from this month, and includes eligible family members aged seven years and above.
Onward support includes medication reviews for ADHD, post-assessment group sessions for autism and ADHD, as well as educational guidance.
Healthcare trust provider Healix also announced a neurodiversity diagnosis and support service for its corporate clients today.
Axa Health said its service aimed at helping neurodivergent members harness their strengths and manage challenges and assist in creating more inclusive workplaces.
Mike Dalby, distribution director of Axa Health said: “We’re really excited to launch this new service and help our clients support their neurodivergent talent, as well as their employees whose family members require neurodevelopmental assessments.
“This innovative service will help us deliver our promise of empowering individuals through better understanding their strengths and challenges and enable workplaces to create inclusive and supportive environments where people can thrive and be themselves.
“Working with ProblemShared will enable us to support members through the process, from initial assessment to diagnosis and support sessions, in a flexible way that works for them.”
Dr Nick Nabarro, founder of ProblemShared, said the firm was delighted to be working with the insurer.
“Together with Axa Health, we ensure that the neurodivergent members are provided with options for diagnosis, education, medication, practical assistance and further treatment where clinically appropriate,” he said.
“This new service represents real change and will provide true support for neurodivergent people to live their best lives.”
